Robert Bradway, MBA

Chair and CEO, Amgen

Robert Bradway, MBA's Bio

Robert A. Bradway is Amgen’s chair and chief executive officer. Bradway became chairman in January 2013 and CEO in May 2012. He served as the company’s president and chief operating officer from May 2010 to May 2012, and was appointed to the Amgen board of directors in October 2011. He joined the company in 2006 as vice president, Operations Strategy, and served as executive vice president and chief financial officer from April 2007 to May 2010.

Prior to joining Amgen, he was a managing director at Morgan Stanley in London, where he had responsibility for the firm’s banking department and corporate finance activities in Europe. Bradway joined Morgan Stanley in New York as a healthcare industry investment banker in 1985 and moved to London in 1990, where he served as head of the firm’s international healthcare investment banking activities until assuming broader corporate finance management responsibilities.

He holds a bachelor’s degree in biology from Amherst College and an MBA from Harvard University. He is a member of the board of Norfolk Southern Corporation.

Recent Work